Asia Healthcare Holdings to acquire majority stake in Asian Institute of Nephrology and Urology for ₹600 crore
The Hindu
Single specialty healthcare delivery platform Asia Healthcare Holdings is acquiring a majority stake in Asian Institute of Nephrology and Urology for ₹600 crore.
Single specialty healthcare delivery platform Asia Healthcare Holdings (AHH) is acquiring a majority stake in Asian Institute of Nephrology and Urology (AINU) for ₹600 crore.
The investment in AINU, which operates seven hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai, will be made through a mix of primary and secondary infusion, AHH said in a release on September 20, without specifying the stake being acquired.
It marks TPG Growth and Singapore’s sovereign wealth fund GIC-backed investing and operating healthcare platform’s foray into urology and nephrology segment. AHH, launched in 2017, owns and operates Motherhood Hospitals network of 23 women and children’s hospital across 11 cities and Nova IVF Fertility chain of 68 IVF centres in 44 cities in India and South Asia. It also built oncology hospital chain CTSI before exiting the company in 2019.
On the latest acquisition, AHH Executive Chairman Vishal Bali said “AINU is a distinct single specialty hospital chain in urology and nephrology built on the foundation of deep clinical expertise and led by clinicians with decades of experience in the specialty. AINU not only adds a new speciality to the AHH platform but also strengthens our vision of scaling the single specialty healthcare delivery ecosystem in the country.”
Founded in 2013 by a team of urologists and nephrologists led by Dr. C. Mallikarjuna and Dr. P.C. Reddy, AINU network has more than 500 beds, treated more than four lakh patients and completed over 50,000 procedures. AINU has completed over 1,000 robotic urology surgeries. “On the nephrology front, it has performed more than 2,00,000 dialysis and 300 kidney transplants,” AHH said.
“We believe AHH has the legacy and the right partner for next phase of growth of our enterprise”, said Dr. Mallikarjuna, who is the Chief Consultant Urologist and Managing Director of AINU.
Setting the backdrop is the emergence of nephrology and urology as one of the fastest growing specialities in the country. AHH said in 2022, India recorded approximately 1.89 crore nephrology and urology procedures and projected to grow at a CAGR of 8-9% over the next five years. There are 6,000 qualified urologists and 3,500 nephrologists in the country. Approximately 350 urologists and 250 nephrologists graduate every year and the rise of laparoscopic, endoscopic and robotic surgical options gives a compelling growth opportunity for AINU to scale across the metros and tier-2 cities in the country.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.
China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.
India's controversial popcorn tax system sparks outrage and criticism, with opposition questioning the complex GST rates.
ICAI President investigates auditing lapses at Byju's, disciplinary committee probing, details undisclosed, part of ongoing investigations.
Sensex and Nifty rebound sharply after steep decline, driven by value buying, bluechip stocks, and global market rally.
AS-IT-IS Nutrition aims for ₹300 crore GMV in 2025 with ATOM range, endorsed by Ravindra Jadeja.
Adani Group acquires Air Works, India's largest MRO company, expanding its aviation services with a ₹400 crore deal.
Sterling and Wilson Renewable Energy Ltd. secures ₹1,200 crore order for 500 MW Solar PV project in Gujarat.